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Introduction
Interactions of cells with the extracellular matrix (ECM) are
primarily mediated by integrins and profoundly influence cell
behavior (Hynes, 2002). Following initial attachment, cell spreading
might occur, depending on the cell type and the additional signals
received. Many processes including proliferation, migration and
survival require both cell adhesion and spreading (Hood and
Cheresh, 2002; Reddig and Juliano, 2005; Schwartz and Assoian,
2001). The latter event involves reorganization of the actin
cytoskeleton and the formation of new and stronger integrin-
substrate adhesions, referred to as focal adhesions (FAs) (Small et
al., 1999). These macromolecular complexes, composed of
transmembrane adhesion receptors, intracellular cytoplasmic
structural proteins and signal transduction molecules are linked to
actin-containing microfilament bundles termed stress fibers (SFs)
(Burridge and Chrzanowska-Wodnicka, 1996).
In some instances, FA formation requires two independent
adhesion receptor-mediated signals. When cells are plated on
fibronectin, one of these signals is generated via interaction of
integrins with the RGD-containing cell-binding domain of
fibronectin. The second signal stems from binding of cell-surface
heparan sulfate proteoglycans (HSPGs) to the heparin-binding
domains (HBD) of fibronectin (Bloom et al., 1999; Woods et al.,
1986). Widespread cooperation between different integrin family
members and syndecans has been reported. However, in all cases,
receptor stimulation is the consequence of engagement by an ECM
protein such as fibronectin, vitronectin or laminin (reviewed by
Morgan et al., 2007).
Essential signaling events initiated by syndecan-4 in cell-to-
matrix adhesion can be bypassed in fibroblasts adhering to the cell-
binding domain of fibronectin by either adding the protein kinase
C (PKC) activator phorbol 12-myristate 13-acetate (Woods and
Couchman, 1992), or stimulating directly the small GTPase RhoA
with lysophosphatidic acid (Saoncella et al., 1999). Furthermore,
FA assembly through syndecan-4 clustering is sensitive to RhoA
inhibition by C3 transferase (Saoncella et al., 1999). Taken together,
these data implicate both PKCα and RhoA-dependent pathways(s)
downstream of syndecan-4. Indeed, it was recently shown that
syndecan-4, PKCα and RhoA activation participate in a linear
pathway that promotes adhesion to the cell matrix in mouse
embryonic fibroblasts (Dovas et al., 2006).
Several reports support the idea that cell surface HSPGs mediate
binding to cell matrix proteins, soluble proteins, viral and bacterial
proteins. HSPGs also act as important cofactors for cytokines,
Clustering of αvβ3 integrin after interaction with the RGD-like
integrin-binding sequence present in neuronal Thy-1 triggers
formation of focal adhesions and stress fibers in astrocytes via
RhoA activation. A putative heparin-binding domain is present
in Thy-1, raising the possibility that this membrane protein
stimulates astrocyte adhesion via engagement of an integrin and
the proteoglycan syndecan-4. Indeed, heparin, heparitinase
treatment and mutation of the Thy-1 heparin-binding site each
inhibited Thy-1-induced RhoA activation, as well as formation
of focal adhesions and stress fibers in DI TNC1 astrocytes. These
responses required both syndecan-4 binding and signaling, as
evidenced by silencing syndecan-4 expression and by
overexpressing a syndecan-4 mutant lacking the intracellular
domain, respectively. Furthermore, lack of RhoA activation and
astrocyte responses in the presence of a PKC inhibitor or a
dominant-negative form of PKCα implicated PKCα and RhoA
activation in these events. Therefore, combined interaction of
the astrocyte αvβ3-integrin–syndecan-4 receptor pair with
Thy-1, promotes adhesion to the underlying matrix via PKCα-
and RhoA-dependent pathways. Importantly, signaling events
triggered by such receptor cooperation are shown here to be
the consequence of cell-cell rather than cell-matrix interactions.
These observations are likely to be of widespread biological
relevance because Thy-1–integrin binding is reportedly relevant
to melanoma invasion, monocyte transmigration through
endothelial cells and host defense mechanisms.
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chemokines and growth factors (Kirkpatrick and Selleck, 2007;
Mahalingam et al., 2007; Park et al., 2000; Swertfeger and Hui,
2001). However, their role in signaling triggered by cell-cell
adhesion is poorly documented.
Findings from this laboratory have implicated Thy-1 membrane
glycoprotein (Thy-1) – a small glycosyl phosphatidylinositol-
anchored protein and member of the immunoglobulin superfamily
that is abundantly expressed on the neuronal surface – in binding
to and clustering of αvβ3 integrin on astrocytes, as well as
triggering the assembly of FAs and SFs (Hermosilla et al., 2008;
Leyton et al., 2001) through the activation of RhoA and ROCK
(Avalos et al., 2004; Avalos et al., 2002). These events require αvβ3
integrin in order to respond to Thy-1 stimulation, since mutation
of the Thy-1-integrin-binding motif (RLD to RLE) prevents its
ability to rapidly induce FA and SF formation in these cells
(Hermosilla et al., 2008; Leyton et al., 2001). However, neuron-to-
astrocyte adhesion is only partially inhibited by recombinant Thy-
1-Fc protein, antibodies to αvβ3 integrin or RGD-like peptides,
suggesting that receptors other than αvβ3 integrin might be
implicated in the association of Thy-1 with astrocytes (Hermosilla
et al., 2008; Leyton et al., 2001). Interestingly, direct Thy-1
interaction with sulfated glycans, as well as the functional
consequences of Thy-1-dependent thymo-epithelial cell adhesion
have been reported (Hueber et al., 1992). Thus, we hypothesized
that Thy-1 increases cell-to-matrix adhesion in astrocytes by
engaging, via cell-cell contact, not only αvβ3 integrin but also
syndecan-4 in a cooperative interaction.
Our findings indicate that Thy-1 interaction with both receptors
can activate the autophosphorylation of FAK in cells in suspension.
Furthermore, Thy-1 interaction with its receptors on the dorsal
surface of matrix-bound astrocytes is required to trigger activation
of RhoA in a PKCα-dependent manner. These signaling events
increased cell adhesion by inducing FAs and SF formation. Thus,
combined interaction of the astrocytic αvβ3 integrin-syndecan-4
receptor pair with a protein present on the surface of a different
cell promotes astrocyte signaling events, as well as adhesion to the
underlying matrix.
There have been several reports of the formation of FAs and cell
contraction requiringα5β1 integrin and syndecan-4 interaction with
ECM proteins (Saoncella et al., 1999; Woods et al., 2000). However,
the study reported here constitutes the first evidence that αvβ3
integrin also requires cooperation with syndecan-4 to lead to FA
and SF formation. This is important given that β1 and β3 reportedly
have different effects on RhoA activity (Bass et al., 2008; Danen
et al., 2002). Additionally, a cluster of positive charges present in
Thy-1 sequence is shown here to be important in Thy-1 interaction
with proteoglycans.
Since the interaction between Thy-1 and integrins has been shown
to mediate cell-cell adhesion in several systems (reviewed by Barker
and Hagood, 2008; Rege and Hagood, 2006) the findings reported
here are likely to be relevant not only to neuron-astrocyte
communication, but also to melanoma invasion, monocyte
transmigration through endothelial cells and host defense
mechanisms.
Results
Heparin inhibits Thy-1-stimulated RhoA activity in astrocytes
Thy-1 has been reported to interact directly with sulfated glycans,
such as heparin, which inhibits adhesion between thymocytes and
thymic epithelial cells (Hueber et al., 1992). If the cellular response
triggered by Thy-1 in astrocytes also depends on a HSPG, such as
syndecan-4, then sulfated glycans should compete with the Thy-1
region that interacts with syndecan-4. Thus, upon confirming the
presence of both syndecan-4 mRNA and protein in the rat astrocyte
cell line used in these studies (supplementary material Fig. S1), the
effect of heparin on Thy-1-stimulated RhoA activity in astrocytes
was investigated. Thy-1-Fc-beads [Thy-1(RLD)-Fc bound to
protein-A–Sepharose beads], previously incubated with increasing
concentrations of heparin (50-400 μg/ml) were used to stimulate
astrocytes. RhoA activity was then measured using the affinity
precipitation assay. As expected, Thy-1-stimulated RhoA activity
in serum-starved astrocytes was reduced by heparin treatment in a
dose-dependent manner (Fig. 1A). These results implicated a
putative Thy-1 heparin-binding domain (HBD) in both binding to
syndecan-4 and activating RhoA.
Heparitinase inhibits focal-adhesion and stress-fiber formation
stimulated by Thy-1 in astrocytes
Thy-1 and syndecan-4 interaction was also evaluated by treating
astrocytes with heparitinase before stimulating the cells with Thy-
1-Fc-beads. The effect of this treatment on FA and SF formation
was then studied by indirect immunofluorescence. Astrocytes were
treated with Thy-1-Fc-beads prepared with either wild-type protein
(containing the RLD motif), or protein containing the RLE mutation.
RLE-containing Thy-1 does not bind to the recombinant αvβ3-Fc
fusion protein (Hermosilla et al., 2008). Furthermore, Thy-1(RLE)-
Fc neither supports astrocyte adhesion nor stimulates FA and SF
formation (Avalos et al., 2002; Leyton et al., 2001).
In heparitinase-treated astrocytes there were not only fewer Thy-
1-stimulated FAs in number but they were also smaller. In addition,
SFs were thinner and less robust than those formed in cells not
digested with heparitinase (Fig. 1B). In the absence of heparitinase
treatment, Thy-1(RLD)-Fc-, but not Thy-1(RLE)-Fc-beads,
stimulated the formation of FAs within 10 minutes, leading to
significantly increased numbers of FAs per cell (Fig. 1C, –Hase,
white bars). Heparitinase treatment blocked stimulation by Thy-1-
Fc-beads and significantly decreased basal levels of FA formation
in all experimental groups compared to untreated cells (Fig. 1C,
+Hase, compared with NS in –Hase, white bars). The average area
of FAs was also quantified for each experimental condition. FAs
increased in size upon stimulation with Thy-1(RLD)-Fc-beads,
whereas no significant effect was seen with Thy-1(RLE)-Fc-beads
(Fig. 1C; –Hase, black bars). Interestingly, a small but significant
difference was still observed in heparitinase-treated cells following
Thy-1(RLD)-Fc stimulation (Fig. 1C, +Hase, black bars).
Thy-1 stimulation of cells in suspension activates signaling in
astrocytes
To demonstrate that the results obtained were due to direct
stimulation of signaling pathways in astrocytes by Thy-1, rather
than alterations in cell-matrix interactions, cells were stimulated in
suspension culture with Thy-1-Fc. In these experiments, FAK
autophosphorylation on tyrosine 397 was employed as a read-out.
Additionally, to avoid effects of the Sepharose beads, Thy-1 was
complexed to protein A in an equimolar ratio. This alternative mode
of stimulation is as efficient as bead-immobilized Thy-1 (N.M. and
L.L., unpublished data). The results obtained by immunoblotting
using phospho-specific antibodies show that Thy-1 induced FAK
phosphorylation on Y397 after 10 minutes and that the increase in
autophosphorylation became statistically significant after 15-20
minutes. The effect of heparin was also tested in this assay by












addition to the cells. A statistically significant reduction in FAK
phosphorylation by heparin was only apparent after 20 minutes of
incubation (Fig. 2). These results suggest that Thy-1 directly
engages integrin-dependent pathways that activate FAK
autophosphorylation. Furthermore, this initial signaling event
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appears to be regulated subsequently by the Thy-1-syndecan-4
interaction.
Thy-1 possesses a heparin binding domain involved in focal
adhesion formation
A putative but as yet unidentified HBD has been reported to exist
in Thy-1 that inhibits thymo-epithelial cell adhesion (Hueber et al.,
1992). Here, a [x37BxxBBBx44] region was detected in the
primary amino acid sequence of Thy-1, where B are basic amino
acids and x represents any amino acid for residues 37-44 (Fig. 3A).
To determine whether this is the putative HBD required for Thy-
1-induced FA and SF formation, the basic motif R38EKRK42 of
Thy-1 was mutated to A38EAAA42, and the proteins were
expressed as Fc fusion molecules. Thy-1-Fc proteins, with or
without mutation in the integrin-binding site (RLD) and/or the HBD
(REKRK) were all recovered by precipitation with protein-
A–Sepharose beads. Thy-1-Fc proteins containing an intact HBD,
but not those with the mutated HBD, could also be precipitated by
heparin-Sepharose, strongly suggesting that the basic motif REKRK
was the sequence required for Thy-1 interaction with heparan sulfate
side chains of proteoglycans (Fig. 3B).
Protein-A beads coated with equivalent amounts of the four
different Thy-1-Fc proteins, or with the supernatant of mock-
transfected cells, were used in the astrocyte stimulation assay. The
only protein able to stimulate astrocytes was the wild-type Thy-1-
Fc, whereas cells treated with beads coated with Thy-1 mutated in
the integrin-binding site, in the HBD, or in both were
indistinguishable from non-treated cells (Fig. 3C). It is noteworthy,
that wild-type Thy-1-Fc was equally active whether it was loaded
Fig. 1. Heparin and heparitinase treatments inhibit Thy-1-stimulated responses
in astrocytes. (A) DI TNC1 cells were serum starved for approximately 16
hours and then stimulated for 2 minutes with 3% fetal bovine serum (FBS,
positive control) or 15 minutes with Thy-1-Fc-beads that had been previously
treated with heparin (50-400 μg/ml) or left untreated for 30 minutes at 4°C.
The cells were then lysed and affinity-precipitated active RhoA or total RhoA
from whole cell lysates were visualized by immunoblotting with anti-RhoA
monoclonal antibody. A representative western blot is shown. The values
indicated were averaged from three independent experiments and indicate the
fold increase in RhoA activity normalized to total protein. (B) DI TNC1
astrocytes were treated with 0.5 mU of heparitinase (+Hase) for 3 hours at
37°C in serum-free medium, or left untreated (–Hase) for the same amount of
time in serum-free medium. The cells were then stimulated for 10 minutes
with Thy-1(RLD)-Fc-beads. Non-stimulated cells (NS) were used as controls.
After the different treatments, cells were washed, fixed and permeabilized.
Focal adhesions (FA) were stained with an anti-paxillin monoclonal antibody
followed by Alexa Fluor 488 anti-mouse IgG (green). Stress fibers (SFs) were
stained with Rhodamine-conjugated phalloidin (red) and were visualized by
confocal microscopy. Scale bar: 15 μm. White squares indicate the areas
shown at a higher magnification in the top row. (C) The average number of
FAs per cell ± s.e.m. (white bars), as well as the average area per FA ± s.e.m.
(black bars), obtained after treating the cells with medium (NS), Thy-1(RLD)-
Fc-beads or Thy-1(RLE)-Fc-beads, were determined for at least 50 cells in
each experimental condition using the ImageJ program and the function
‘Analyze particles’. The values shown were obtained by averaging data from
at least three independent experiments. Non-parametric Mann-Whitney
analysis was used to compare the data. Significant differences are indicated
between NS and stimulated cells treated (+Hase) and non-treated (–Hase) with
heparitinase (*P<0.05). Significant differences are indicated in the average
number of FAs per cell (white bars) between cells in the presence (+Hase) or
the absence (–Hase) of heparitinase treatment (**P<0.05).
Fig. 2. Thy-1 stimulates FAK autophosphorylation of cells in suspension.
Astrocytes in suspension (2105 cells) were treated for the indicated period of
time with Thy-1(RLD)-Fc complexed to protein A (4:0.4 μg/tube), pre-
incubated or not with heparin (200 μg/ml). Then, cells were rinsed with cold
PBS and lysed in Laemmli buffer. Total protein extracts from DI TNC1
astrocytes were separated by SDS-PAGE and analyzed by western blotting
with anti-pY397FAK antibodies. Tyrosine phosphorylated FAK levels were
quantified by scanning densitometric analysis of western blots and normalized
to actin (graph). Phosphorylated Y397FAK levels in astrocytes treated with
either Thy-1(RLD)-Fc (white bars) or heparin-treated Thy-1(RLD)-Fc (black
bars) at different time points were compared with those in the non-stimulated
control (gray bar). Results shown are the means ± s.e.m. of data from three
independent experiments. Non-parametric Mann-Whitney analysis was used to
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on beads directly from supernatants of transfected cells (Fig. 3C)
or as purified protein (see below) and that cells treated with the
control beads behaved as non-stimulated astrocytes (data not
shown). Taken together, these results confirm that both the integrin-
binding site and the HBD of Thy-1 are required to stimulate
astrocyte adhesion.
Expression of a syndecan-4 siRNA interferes with focal-
adhesion and stress-fiber formation stimulated by Thy-1 in
astrocytes
To more rigorously explore the role of syndecan-4 on FA and SF
formation, we employed small interference RNA (siRNA) to knock
down endogenous syndecan-4 protein expression in astrocytes.
siRNA constructs designed to match non-conserved 21 nucleotide
sequences within the syndecan-4 mRNA were transfected into DI
TNC1 astrocytes. Semi-quantitative RT-PCR was employed to detect
levels of syndecan-4 message in cDNA derived from astrocytes
transfected with different combinations of siRNA. A substantial
decrease in syndecan-4 mRNA levels was observed in cells treated
with all combinations of siRNA as compared to control siRNA
treated cells (Fig. 4A). Note that decreased syndecan-4 mRNA levels
correlated with increased residual amounts of syndecan-4-specific
primers in the PCR reaction mixture (lower band in Fig. 4A).
To test whether low levels of mRNA correlated with decreased
protein expression, syndecan-4 was detected by western blot
analysis in lysates from transfected cells. Lysates were previously
treated with heparitinase to liberate the core proteins of all
syndecans. A readily detectable decrease (>50%) in syndecan-4
protein levels was also observed in syndecan-4 siRNA-treated cells
(mix 1+2 or 2+3), as compared to either untreated or control siRNA-
treated cells (Fig. 4A, protein blot and graph). Taken together, these
results demonstrated that the specific siRNA combinations (mix 1+2
or 2+3) can efficiently and specifically reduce the amount of
syndecan-4 protein in transfected astrocytes.
Next, we studied the requirement for syndecan-4 in Thy-1-
induced FA and SF formation in astrocytes. Syndecan-4 siRNA
(mix 1+2) was co-transfected with EGFP-containing plasmid to
identify those cells that had incorporated the probes. Cells were
stimulated as before with Thy-1-Fc-beads or with neuronal CAD
cells which express high levels of Thy-1 on their surface. Previous
reports indicate that these cells induce FA and SF formation in
astrocytes exclusively via Thy-1-αvβ3 integrin interaction
(Hermosilla et al., 2008). GFP-positive astrocytes co-transfected
Fig. 3. Mutation of the heparin binding domain of Thy-1 renders the protein
unable to bind heparin and to promote focal-adhesion formation. (A) Partial
sequences (amino acids 1-45) of rat, mouse and human Thy-1. Underlined
amino acid residues are almost identical for all three species. Gray boxes
indicate the integrin-binding sequence (RLD) and the putative heparin-binding
domain (REKRK) present in Thy-1. Mutations in both integrin- and heparin-
binding domains were obtained by the double-PCR technique to obtain four
different forms of the secreted Thy-1-Fc molecules by transiently transfecting
HEK293T cells: wild-type Thy-1(RLD), integrin-binding-site-mutated Thy-
1(RLE), double-mutated Thy-1(RLE)(AEAAA), HBD-mutated Thy-
1(RLD)(AEAAA). (B) The aformentioned wild-type and mutated Thy-1-Fc
proteins were precipitated from supernatants with protein-A-Sepharose or
heparin-Sepharose, and analyzed by western blotting using anti-human IgG (Fc
specific)-HRP. Additionally, the supernatant of cells transfected with pEGFP-
C1 alone was used as a control. (C) The effect of these proteins on FA
formation was tested and evaluated by immunofluorescence as indicated in Fig.
1C. White bars, the number of focal adhesions per cell; black bars, the area of
focal adhesions. Values shown are mean ± s.e.m. of data from at least three
different experiments. Non-parametric Mann-Whitney analysis was used to
compare the data. Statistically significant differences are indicated (*P<0.05).
Fig. 4. Silencing of syndecan-4 with siRNA transfections decreases focal-
adhesion and stress-fiber formation stimulated by Thy-1. Syndecan-4 silencing
was performed by co-transfecting pEGFP-C1 with different siRNA directed
against syndecan-4. (A) Expression levels of syndecan-4 and actin mRNA or
syndecan-4 and syndecan-2 protein, in either non-transfected cells (Control) or
cells transfected with siRNA control (Co siRNA) or different mixes of
syndecan-4-specific siRNA, were measured by semi-quantitative RT-PCR or
western blots, respectively. Bands obtained for syndecan-4 (S-4) and
syndecan-2 (S-2) by western blot were quantified by densitometry and results
are presented as average ratio ± s.e.m. between values obtained (S-4/S-2) from
three independent experiments. (B) Astrocytes were co-transfected with
pEGFP-C1 (Control GFP+) and either control siRNA or siRNA (1+2). After
allowing GFP expression, cells were stimulated with Thy-1-Fc-beads for 10
minutes. The graph shows the percentage of GFP-positive cells that were
stimulated by Thy-1 under each condition. Cells were scored as stimulated
when elongated focal adhesions were present and there was at least a 1.5-fold
increase in the number of focal adhesions per cell. Data were obtained from
three independent experiments. Values mean ± s.e.m. calculated from counting












with syndecan-4 siRNA did not respond as well to either CAD
cells or to Thy-1-Fc-beads when compared to those transfected
with the control siRNA or pEGFP-C1 only (not shown). These
observations were verified by quantifying the number of GFP-
transfected cells that contained Thy-1-stimulated FAs. Those cells
that contained elongated FAs and showed at least a 1.5-fold increase
in the number of FAs compared to non-stimulated cells were scored
as GFP-positive cells with FAs. More than 80% of GFP-expressing
cells co-transfected (81±4%) or not (89±6%) with control siRNA
responded to Thy-1-Fc-beads by forming more and larger FAs.
However, a smaller percentage of GFP-positive cells co-transfected
with siRNA for syndecan-4 (34±15%) were stimulated by Thy-1-
Fc-beads (Fig. 4B). Similar results, obtained when using CAD cells
to stimulate astrocytes (not shown), suggest that neuronal Thy-1
requires the presence of syndecan-4 to induce a cellular response
in astrocytes.
Expression of a syndecan-4 mutant interferes with focal-
adhesion formation stimulated by Thy-1 in astrocytes
Syndecan-4-dependent signaling relies on the variable region
located in its cytoplasmic domain (reviewed by Couchman and
Woods, 1999). To demonstrate that Thy-1-stimulated FA and SF
formation requires not only binding to syndecan-4, but also
syndecan-4 signaling, astrocytes were transiently co-transfected with
full-length syndecan-4 [(wt)syndecan-4] or a mutant of syndecan-
4 lacking the cytoplasmic domain [(m)syndecan-4] (Keum et al.,
2004) and pEGFP-C1. Transfections were corroborated by
microscopy or cell cytometry to detect GFP-positive cells (not
shown), and by RT-PCR to confirm the presence of the respective
mRNA (supplementary material Fig. S2). In the non-transfected
cells, present in all transfection conditions (GFP negative cells), a
similar number of cells with FAs was observed in the absence of
stimulation (not shown). Expression of (wt)syndecan-4, under non-
stimulated conditions, increased the number of cells that had FAs
with respect to cells transfected with EGFP only or with
(m)syndecan-4 (Fig. 5A,B and Fig. 5E, gray bars). Accordingly,
RhoA activity was also increased (compare GFP with wtS4 lanes
in Fig. 5F under non-stimulated conditions). However, introduction
of (wt)syndecan-4 affected neither FA formation induced by Thy-
1 (Fig. 5D; Fig. 5E, black bars) nor RhoA activity [compare GFP
with wtS4 lanes in Fig. 5F, +Thy-1(RLD)]. By contrast,
(m)syndecan-4-expressing cells lost responsiveness to Thy-1
stimulation (compare Fig. 5C and D), since fewer cells with FAs
were detectable (Fig. 5E, black bars). In agreement with the
previous results, obtained by silencing syndecan-4, transfection with
(m)syndecan-4 decreased the percentage of GFP-positive cells
responsive to Thy-1 to 27±3%. However, around 60% of the GFP-
positive cells were stimulated by Thy-1 treatment in cells transfected
with (wt)syndecan-4 (59±9%) or pEGFP-C1 vector (67±6%; Fig.
5E, black bars). As expected, levels of active RhoA did not change
following Thy-1 treatment of cells transfected with (m)syndecan-
4 lacking signaling properties (Fig. 5F).
PKCα inhibition decreases focal-adhesion and stress-fiber
formation and RhoA activity stimulated by Thy-1 in astrocytes
Since syndecan-4-dependent signal transduction involves the
formation of a ternary complex with PtdIns(4,5)P2 and PKCα, as
well as PKCα activation (Couchman, 2003), we studied the
participation of PKCα in Thy-1-mediated responses. To this end,
astrocytes were treated with the inhibitor Gö 6976, which, at low
concentrations is highly selective for the PKC isoforms α, β and γ
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(Martiny-Baron et al., 1993). Cells stimulated with Thy-1(RLD)-
Fc-beads contained a significantly greater number of FAs per cell
and FAs of larger average size, than non-stimulated cells (Fig. 6B,
white bars). Treatment with vehicle (0.01% DMSO) did not affect
FA and SF formation in either non-stimulated cells or cells
stimulated with Thy-1(RLD)-Fc-beads (left panels in Fig. 6A and
gray bars in B). Treatment with Gö 6976 (100 nM) significantly
decreased the number and size of FAs in Thy-1-stimulated astrocytes
(right panels in Fig. 6A and black bars in B), compared with cells
treated with vehicle.
The effect of PKCα inhibition with Gö 6976 on Thy-1-stimulated
RhoA activity was also evaluated. Astrocytes were serum-starved
and then treated with either 10 nM or 100 nM inhibitor, before being
Fig. 5. Transfection of astrocytes with a syndecan-4 mutant lacking the
cytoplasmic domain decreases Thy-1-stimulated focal-adhesion formation.
Cells were transiently co-transfected with EGFP-containing plasmid and either
truncated (A,C) or wild-type (B,D) syndecan-4. DI TNC1 astrocytes were then
left unstimulated (NS; A,B) or were stimulated with Thy-1(RLD)-Fc-beads
[+Thy-1(RLD); C,D]. Samples were analyzed by immunofluorescence using
mouse anti-paxillin antibodies followed by Cy3-labeled anti-mouse IgG. Red
and green colors were inverted to improve visualization of focal adhesions;
therefore, in images obtained using confocal microscopy, focal adhesions are
in green in both non-transfected (no color) and GFP-transfected (red) cells.
Scale bar: 25 μm. (E) Quantification of cells with focal adhesions within the
transfected cell population in each transfection condition (GFP+) is shown for
non-stimulated (gray bars) and Thy-1-stimulated cells (black bars). Cells with
focal adhesions were evaluated as indicated in Fig. 4. Values were obtained by
evaluating at least 100 GFP-positive cells per condition from three
independent experiments. Statistically significant differences are indicated
between values obtained for wild-type syndecan-4 with either transfected
control (**P<0.05) or mutated syndecan-4 (*P<0.05). (F) Transfected DI
TNC1 cells were serum-starved overnight and then stimulated or not (NS) for
15 minutes with Thy-1-Fc-beads [+Thy-1(RLD)]. The cells were then lysed
and active RhoA was affinity-precipitated with RBD-GST-beads. RhoA was
visualized by immunoblotting as indicated in Fig. 1A. A representative result
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stimulated with Thy-1(RLD)-Fc-beads. As expected, Gö 6976
decreased, in a concentration-dependent manner, RhoA activity
stimulated by Thy-1 in astrocytes (Fig. 6C).
Dominant-negative PKCα inhibits focal-adhesion and stress-
fiber formation as well as RhoA activity stimulated by Thy-1 in
astrocytes
To further evaluate the participation of PKCα in Thy-1-triggered
responses, astrocytes were transduced with adenoviral vectors
encoding wild-type (wt) or dominant-negative (dn) PKCα and their
effect on RhoA activity, as well as FA and SF formation was
evaluated. In order to determine the multiplicity of infection (MOI)
required to achieve optimal transduction efficiency, astrocytes were
transduced with increasing MOI (1-10,000) of adenoviral vectors
encoding β-galactosidase or GFP and 24 hours later, the respective
parameter (β-galactosidase activity or the number of green versus
non-green cells) was measured. According to results obtained,
astrocytes required a MOI of 1000 for 100% transduction efficiency
(data not shown).
Therefore, astrocytes were transduced with adenovirus containing
empty vector (negative control), (wt)PKCα or (dn)PKCα. PKCα
expression was evaluated at three different MOI by western blot
analysis. As expected, PKCα protein levels increased using MOI
up to 1000, both in (wt)- and (dn)PKCα-transduced cells, but not
in cells transduced with empty vector (Fig. 7A). Densitometric
analysis indicated that PKCα protein levels increased approximately
threefold in (wt)PKCα- and (dn)PKCα-transduced cells using a
MOI 1000 (not shown).
After transducing the astrocytes with adenoviral empty vector,
cells treated with Thy-1(RLD)-Fc-beads formed FAs as expected
(compare lower with upper panels in Fig. 7B). When transducing
Fig. 7. The expression of a dominant-negative mutant of PKCα reduces the
formation of focal adhesions and stress fibers, as well as RhoA activity in
astrocytes. (A) DI TNC1 cells were transduced with adenoviral vectors for wild
type (wt) and dominant-negative (dn)PKCα, and empty vector using MOIs of
0, 300, 600 and 1000. After 24 hours, astrocytes were lysed and samples were
analyzed by immunoblotting with anti-PKCα antibodies. Rat brain extract was
used as a positive control (+C) for PKCα. Bands of 80 and 45 kDa correspond
to full-length and the catalytic region of PKCα, respectively. (B) Astrocytes
were transduced with empty or (dn)PKCα adenoviral vectors using a MOI of
1000. After 24 hours, cells were seeded on coverslips and, the next day,
stimulated with Thy-1(RLD)-Fc-beads, or left unstimulated (NS). Focal
adhesions and stress fibers were visualized by immunofluorescence as detailed
in Fig. 1B. Scale bar: 25 μm. (C) Astrocytes were transduced with empty
vector (light gray bars), (wt)PKCα (dark gray bars), (dn)PKCα (black bars) as
in B or were not transduced (white bars). Cells were then stimulated with Thy-
1(RLD)-Fc-beads, treated with TRAIL-R2-Fc-beads (negative control) or not
stimulated (NS). For each experimental condition, the number of FAs per cell
and the average size of FAs were determined as for Fig. 1C. Values shown are
mean ± s.d. of one representative experiment performed in duplicate.
(D) Astrocytes were transduced with the different adenoviral vectors described
in C and RhoA activity was measured as in Fig. 1A. Results are representative
of two independent experiments.
Fig. 6. Pharmacological inhibition of PKCα reduces the formation of focal
adhesions and stress fibers, as well as RhoA activity in astrocytes. (A) DI
TNC1 cells were treated with 100 nM Gö 6976, left untreated or treated with
0.01% DMSO (vehicle) for 30 minutes at 37°C in serum-free medium and
were then either stimulated with Thy-1(RLD)-Fc-beads for 10 minutes or not
stimulated (NS). Samples were analyzed by immunofluorescence as described
in Fig. 1B. Scale bar: 25 μm. (B) The number of FAs per cell and the average
area of FAs were determined as for Fig. 1C. Values shown are mean ± s.e.m.
of data from at least three different experiments. Significant differences are
indicated (**P<0.05) between NS cells and cells stimulated with Thy-1(RLD)-
Fc-beads, for the indicated conditions (–DMSO, white bars; + DMSO, gray
bars). A significant difference (#P<0.05) is indicated between cells treated or
not with Gö 6976 (black bars versus gray bars) in Thy-1(RLD)-Fc-stimulated
cells. (C) Astrocytes were serum-starved and then treated with either 10 nM or
100 nM Gö 6976 before stimulating with Thy-1(RLD)-Fc-beads for 15
minutes. Active RhoA levels were determined as described in Fig. 1A.
Controls included starved cells and cells stimulated with 3% fetal bovine













the cells with (dn)PKCα adenoviral vector, Thy-1 no longer
stimulated these astrocytes and a reduction in the number and size
of FAs was observed when compared with cells transduced with
empty vector (lower panels in Fig. 7B). Transduction with
(dn)PKCα also decreased SF formation in cells stimulated with Thy-
1(RLD)-Fc beads, whereby a reduction in the thickness of these
structures was apparent (Fig. 7B).
Quantification of FAs per cell in each of the above conditions,
as well as in non-transduced cells and cells transduced with
(wt)PKCα indicates that only those cells over-expressing (dn)PKCα
could not be stimulated with Thy-1(RLD)-Fc-beads (black bars in
Fig. 7C). In non-transduced cells (white bars), cells transduced with
empty vector (light gray bars) or with (wt)PKCα (dark gray bars),
stimulation with Thy-1-Fc-beads increased the number of FAs per
cell and the average size of FAs, compared with the corresponding
controls (NS or TRAIL-R2-Fc beads; Fig. 7C). Interestingly,
overexpression of (wt)PKCα did not alter the number of FAs per
cell, but did alter the size in both non-stimulated and TRAIL-R2-
Fc-treated cells (Fig. 7C).
Finally, RhoA activation in cells overexpressing the different
forms of PKCα was analyzed. Even though the adenoviral
transducing procedure decreased RhoA activity in all cases, the
inhibitory effect of (dn)PKCα on RhoA activity upon Thy-1
stimulation was more pronounced than when using (wt)PKCα or
empty vector (Fig. 7D).
Discussion
In this study, we have shown that Thy-1 functions in cell-cell
signaling via dual interaction with αvβ3 integrin and syndecan-4.
Engagement of these two receptors leads to FA and SF formation
in astrocytes, increasing their adhesion to the underlying matrix.
To date, the following cooperative interactions of integrins and
syndecans with the extracellular matrix have been reported to
increase adhesion: (1) α5β1 integrin and syndecan-4 with
fibronectin (Bloom et al., 1999; Woods et al., 1986); (2) αvβ3
integrin, αvβ5 integrin and syndecan-1 with vitronectin (Beauvais
et al., 2004; McQuade et al., 2006), and (3) α2β1 integrin, α6β4
integrin and syndecans with laminin (Hozumi et al., 2006; Ogawa
et al., 2007). These examples underscore the fact that cooperation
between these types of receptors has so far been viewed as a matrix-
rather than a cell-initiated signaling process. Interestingly, despite
the distinct nature of the ligand implicated in this case, namely Thy-
1, similar signaling molecules are activated downstream, including
PKCα and RhoA. Additionally, since β1 and β3 reportedly activate
RhoA in distinct manners upon binding to fibronectin (Danen et
al., 2002), signaling pathways triggered by Thy-1 engagement of
αvβ3 integrin and/or syndecan-4 were not necessarily expected to
be identical to those triggered by ECM proteins.
Heparin competed with syndecan-4 for Thy-1-HBD, thereby
reducing Thy-1-mediated RhoA activation (Fig. 1A). Studies
performed in other cell types have demonstrated that heparin also
decreases FA and SF formation by binding to the HBD of fibronectin
(Bloom et al., 1999; Midwood et al., 2004; Mostafavi-Pour et al.,
2003). Thus, the effect of heparin on RhoA activity reported here
suggests that Thy-1 regulates this GTPase activity through
syndecan-4. Additionally, heparin also inhibited FAK
autophosphorylation at 20 minutes, but not at 15 minutes after Thy-
1 stimulation of cells in suspension. Since FAK autophosphorylation
on Y397 is triggered by Thy-1 via engagement of αvβ3 integrin
(Leyton et al., 2001) and syndecan-4 is reported to regulate
phosphorylation of FAK on this tyrosine residue (Wilcox-Adelman
Journal of Cell Science 122 (19)
et al., 2002), these results implicate both integrin and syndecan-4
in this signaling response. Moreover, they confirm the interpretation
that heparin is exerting its effect by impeding interactions that
require the HBD of Thy-1, rather than by disrupting constitutive
cell-matrix interactions.
Heparitinase treatment to digest heparan sulfate chains present
on the surface of astrocytes, not only blocked the number of FAs
in astrocytes stimulated by Thy-1-Fc-beads, but also decreased the
basal number of FAs in non-stimulated cells (Fig. 1C, white bars).
These observations most probably indicate that heparitinase has
additional effects on the interactions of cells with their underlying
matrix. Even though the number of FAs was not elevated by
stimulation with Thy-1-Fc-beads, the size of these structures
increased significantly (Fig. 1C, black bars), indicating that Thy-
1-induced responses were not completely prevented by heparitinase
treatment. This residual signaling may be due to incomplete
heparitinase digestion or direct signaling mediated by either Thy-
1 and integrin or Thy-1 and syndecan-4(core) interaction. The latter
has been previously reported for fibronectin interaction with
syndecan-4 (Echtermeyer et al., 1999).
In contrast to cells stimulated with Thy-1(RLD)-Fc-beads,
stimulation with Thy-1(RLE)-Fc-beads did not significantly increase
the number of FAs (Fig. 1C, Fig. 3C). This mutation hampers Thy-
1 interaction with integrin αvβ3 but does not affect the putative
HBD of the molecule. Therefore, the results suggest that Thy-1
interaction with syndecan-4 alone cannot induce the formation of
FAs and SFs. Additionally, no effect was observed on FA formation
when treating astrocytes with either the single [Thy-
1(RLD)(AEAAA)-Fc] or double [Thy-1(RLE)(AEAAA)-Fc] HBD
mutant immobilized on beads (Fig. 3C). Intriguingly, the single
mutant containing intact RLD sequence did not induce changes in
astrocyte adhesion indicating that, under the conditions used, both
the integrin-binding site and the HBD of Thy-1 are required to
stimulate FA formation in astrocytes (see below).
Syndecan-4 involvement in Thy-1-induced cellular responses was
corroborated by silencing expression of the protein with siRNA.
Thy-1 stimulation was not observed in syndecan-4 knockdown cells
(Fig. 4). Likewise, overexpression of a mutant lacking the
intracellular portion of syndecan-4, precluded FA and SF formation
as well as the increase in RhoA activity induced by Thy-1 (Fig. 5),
indicating not only that syndecan-4 engagement is required, but
also that the signaling cascade emanating from the cytoplasmic
domain of this receptor is essential. We propose that in the absence
of syndecan-4 binding and signaling, FAs are unstable and undergo
rapid turnover. However, in the presence of syndecan-4, astrocyte
stimulation with only the RLD peptide bound to microspheres
appears as effective as with the whole Thy-1 molecule (Hermosilla
et al., 2008). Presumably, this may be explained by the fact that in
those reported experiments, cells were attached to their own matrix
and, therefore, syndecan-4 was already engaged by ECM proteins
in stabilizing focal adhesions.
A minimum lateral spacing of 58 nm between nanogold-
anchored RGD peptides is reported to be crucial for induction of
FA formation (Arnold et al., 2004; Koo et al., 2002; Maheshwari
et al., 2000). However, ligand density for both integrin and
syndecan-4 have been shown to be crucial for FA formation,
whereby each receptor appears to play a unique role in generating
the response (Bass et al., 2007). These controversial findings
indicate that composition and strength of the primary signal are
important in determining the final cellular outcome. Thus, results
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[Thy-1(RLD)(AEAAA)-Fc] which, despite containing the integrin-
binding site did not induce FA formation, may indicate that either
higher amounts of the mutated Thy-1 are required to trigger the
responses or that, as indicated above, both binding sites (for integrin
and heparin) are necessary to control the dynamics of the adhesive
response. Interestingly, the consensus sequences that reportedly act
as heparin-binding regions were not detected in the Thy-1 primary
sequence (Hueber et al., 1992). Here, we report that the mutation
of a cationic motif completely abolished Thy-1 binding to heparin
(Fig. 3B), indicating that this motif is required for Thy-1 interaction
with heparin.
Cell spreading and the formation of FAs and SFs through
syndecan-4, not only depend on Rho, but also on PKCα activation
in some cell types (Dovas et al., 2006; Koo et al., 2006; Woods
and Couchman, 1992). Thus, participation of PKCα in Thy-1-
stimulated responses in astrocytes was studied. Indeed, results
presented here (Figs 6 and 7) suggest that RhoA activation via
syndecan-4 in astrocytes requires PKCα activation. However, they
do not shed light on whether PKCα activation depends directly or
exclusively on syndecan-4 engagement. A possible substrate for
PKCα is Rho-GDI, whereby Rho-GDI phosphorylation leads to
dissociation from Rho, which in turn permits RhoA activation
(Mehta et al., 2001; Pan et al., 2005). Thus, the possibility that Rho-
GDI functions as an intermediate between PKCα and RhoA in this
syndecan-4-dependent pathway is currently being explored.
The ubiquitous distribution of syndecan-4 is generally associated
with low levels of expression (Kim et al., 1994; Yoneda and
Couchman, 2003). Therefore, syndecan-4 function might be more
relevant in situations where its expression increases. Reportedly,
syndecan-4 is upregulated during wound healing and localizes to
wounded areas (Cizmeci-Smith et al., 1997; Gallo et al., 1996; Gallo
et al., 1994). Additionally, although syndecan-4 knockout mice are
healthy, delays in tissue repair mechanisms and impaired
angiogenesis have been observed (Echtermeyer et al., 2001). There
is also evidence for increased syndecan expression in reactive
astrocytes upon brain injury (Iseki et al., 2002). Syndecans could,
via interaction with Thy-1 in neurons, enhance astrocyte contraction,
wound healing and scar formation. In doing so, an environment
that prevents neuronal regeneration would be created.
However, Thy-1-integrin binding is also important to interactions
between melanomas or monocytes and/or neutrophils and activated
endothelial cells (Saalbach et al., 2005; Wetzel et al., 2004; Wetzel
et al., 2006). In the latter case, Thy-1 promotes strong adhesion of
the cells to the endothelium to favor subsequent migration across
this cell layer. Endothelial cells are activated in inflammatory
processes. Therefore, it is possible that the cells interacting with
them, such as melanomas and monocytes, upregulate syndecan-4
under these conditions. Thus, these syndecan-4-dependent
interactions are likely to be relevant to a variety of pathological
conditions. In summary, it is highly probable that the dual interaction
of Thy-1 with integrins and syndecan-4 will also be important for
these other events that require cell-cell interactions.
Materials and Methods
Cells, recombinant proteins and reagents
The rat astrocytic cell line DI TNC1 (ATCC CRL-2005) was used in these studies
and these cells were maintained as described previously (Hermosilla et al., 2008).
Human embryonic kidney 293T cells (HEK293T, ATCC CRL-11268) were grown
according to ATCC guidelines. Cells were maintained in a humidified atmosphere
of 5% CO2 and 37°C.
Reagents used were heparin and heparitinase III (EC 4.2.2.8, Sigma), siPORT
Amine transfection reagent (Ambion), Fugene HD transfection reagent (Roche) and
Lipofectamine Plus (Invitrogen). The recombinant proteins Thy-1(RLD)-Fc, Thy-
1(RLE)-Fc and TRAIL-R2-Fc were obtained as previously reported (Leyton et al.,
2001) and coupled to protein-A–Sepharose beads (Sigma) for cell stimulation.
Additionally, the putative Thy-1 heparin-binding domain REKRK was mutated to
AEAAA by a conventional, PCR-based technique to obtain the mutants [Thy-
1(RLD)(AEAAA)-Fc and Thy-1(RLE)(AEAAA)-Fc]. The fusion proteins were
expressed by transient transfection of HEK293T cells using Lipofectamine Plus
according to the manufacturer’s instructions. Recombinant proteins were purified from
the supernatants (4 ml) using protein-A–Sepharose beads (80 μl of 50% slurry) and
employed for immunoblotting and cell stimulation experiments. GST-RBD fusion
protein employed in the affinity precipitation assay was obtained as previously
described (Avalos et al., 2004). DNAs were purified using a Qiagen Plasmid
Purification Kit. Full-length syndecan-4 cDNA (Syn 4W) and a mutant cDNA lacking
the cytoplasmic domain (Syn 4R) were kindly provided by Eok-Soo Oh (Department
of Life Sciences, Ewha Womans University, Seoul, South Korea) (Keum et al., 2004).
Adenoviral vectors for expression of wild-type and dominant-negative PKCα (which
contains a mutation in the ATP-binding region, K368R) were from Seven Hills
Bioreagents (Cincinnati Children’s Hospital Medical Center, Cincinnati, OH). These
vectors were generated and characterized as described previously (Braz et al., 2002;
Matsumoto et al., 2001; Ohba et al., 1998) using the AdEasy adenoviral vector system
(He et al., 1998).
Rhodamine-conjugated phalloidin (Sigma) and the antibodies mouse anti-vinculin
(Sigma) or anti-paxillin monoclonal antibody (Transduction Laboratories), goat anti-
mouse Alexa Fluor 488 polyclonal antibodies (Molecular Probes) and Cy3-labeled
anti-mouse IgG (Bio-Rad) were used in immunofluorescence experiments. Antibodies
used for western blots were mouse anti-Δ-heparan sulfate (3G10, Seikagaku), mouse
anti-RhoA monoclonal antibody (Santa Cruz Biotechnology), rabbit anti-pY397FAK
polyclonal antibody (Upstate Biotechnology), horseradish peroxidase (HRP)-coupled
goat anti-mouse or anti-rabbit IgG polyclonal antibodies (Bio-Rad) and anti-human
IgG (Fc specific)-HRP (Jackson ImmunoResearch). Specifically bound HRP-
conjugated antibodies were visualized using the ChemiLucent Detection System Kit
(Chemicon International). The BCA reagent (Pierce Chemical) was used to determine
the protein concentration. All other reagents used for immunofluorescence, affinity
precipitation assays and western blots were from Sigma or of the highest grade
available.
Digestion with heparitinase
Cells grown to confluency in 10-cm plates were lysed with 1 ml of cold buffer
containing 50 mM Tris-HCl pH 7.4, 100 mM NaCl, 0.5% Triton X-100 and protease
inhibitors (10 μg/ml benzamidine, 2 μg/ml antipain, 1 μg/ml leupeptin), as well as
the phosphatase inhibitors (1 mM sodium orthovanadate and 0.5 mM sodium fluoride).
Lysates were centrifuged at 13,000 g for 5 minutes at 4°C and the protein concentration
in supernatants was measured using the BCA method. Each sample (45 μg) was
digested for 3 hours at 37°C with 0.3 mU of heparitinase resuspended in 10 μl of
buffer: 20 mM Tris-HCl pH 7.4 containing 50 mM NaCl and 2 mM CaCl2. As a
control, undigested samples were also prepared by incubating them only with 10 μl
of the digestion buffer mentioned. Samples were then boiled for 5 minutes in Laemmli
buffer (Laemmli, 1970). Proteins were separated by SDS-PAGE on 8% gels,
transferred onto PVDF membranes (Millipore), blocked in 5% non-fat milk solution
in PBS plus 0.05% Tween 20 and probed with anti-Δ-heparan sulfate antibodies
followed by incubation with HRP-conjugated secondary antibodies.
RhoA activity assay (affinity precipitation)
RhoA activity was measured using the affinity precipitation assay described previously
(Avalos et al., 2004). Astrocytes were grown in 6-cm plates and, after serum
deprivation, were stimulated for 15 minutes with 20 μg of Thy-1(RLD)-Fc bound to
20 μl of protein-A–Sepharose beads (Thy-1-beads). Thy-1-beads were previously
incubated or not with different concentrations of heparin (50-400 μg/ml) for 30 minutes
at 4°C. In other experiments, cells were incubated for 30 minutes with the PKC
inhibitor Gö 6976 (10 nM or 100 nM) or vehicle (0.01% DMSO) in serum-free
medium, before being stimulated with Thy-1-beads. Astrocytes grown to 40%
confluency in 6-cm dishes were co-transfected with wild-type or mutated syndecan-
4 and pEGFP-C1 DNA (10:1) using Fugene HD transfection reagent according to
the manufacturer’s instructions. Astrocytes were also transduced in suspension with
adenoviral vectors encoding wild-type, dominant-negative PKCα or empty vector
(MOI = 1000). Following transduction (24 hours), astrocytes were serum-starved for
the assay. The densitometric analysis was performed as reported previously (Avalos
et al., 2004).
Western blotting
Astrocytes (2105 cells) suspended in 400 μl of serum-free medium were incubated
for 30 minutes prior to stimulation with Thy-1(RLD)-Fc complexed to protein A.
Complexes were formed by incubating Thy-1(RLD)-Fc:protein A (10:1) in serum-
free medium for 1 hour at 4°C on a rotating wheel. Then, 4 μg of Thy-1(RLD)-Fc
complexed to 0.4 μg of protein A were added to each tube. To test the heparin effect
in this assay, complexes were incubated for an additional 30 minutes with heparin
(200 μg/ml) before adding them to the cells. Thy-1(RLD)-Fc–protein-A complexes
were incubated at 37°C for 10, 15 or 20 minutes. Cell stimulation was stopped by
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Laemmli buffer containing protease inhibitor cocktail and tyrosine phosphatase
inhibitors, as indicated previously. Proteins were separated by SDS-PAGE in 10%
minigels and electrotransferred to nitrocellulose. The immunoblot was probed with
an anti-phospho-specific antibody to Y397FAK, which was detected with a secondary
antibody conjugated to HRP. The densitometric analysis was as reported previously
(Avalos et al., 2004).
Mutated Thy-1 proteins present in supernatants of transiently transfected HEK293T
cells were recovered with protein A beads (10 μl of beads per ml of supernatant) by
incubating them at 4°C for 1 hour on a rotating wheel. The heparin binding capacity
of the mutated Thy-1 proteins was tested in a similar manner but using 10 μl of
heparin-Sepharose beads. Upon incubation, both protein-A beads and heparin beads
were washed twice with cold PBS before solubilization of bound proteins with
reducing Laemmli buffer containing protease and phosphatase inhibitors, as indicated
above. Solubilized proteins were separated by SDS-PAGE in 10% minigels and
electrotransferred to nitrocellulose. Immunoblots were probed with anti-human IgG
(Fc specific)-HRP and binding was revealed using the chemiluminescent detection
system kit.
Indirect immunofluorescence
Astrocytes (3104 cells) were seeded on sterile 12-mm coverslips in 24-well plates
in complete RPMI medium 12 hours before experiments were initiated. Then,
astrocytes were incubated either with 0.5 mU of heparitinase for 3 hours in 400 μl
of serum-free medium or with the inhibitor Gö 6976 (100 nM) or corresponding
vehicle (0.01% DMSO) in serum-free medium for 30 minutes at 37°C. Astrocytes
were also transiently co-transfected with EGFP containing plasmid and syndecan-4
siRNA using siPORT Amine transfection reagent, or with EGFP- and wild-type or
truncated syndecan-4-containing plasmids using Lipofectamine Plus reagent,
following the manufacturer’s instructions. In other experiments, astrocytes were grown
in 6-cm plates and, after 24 hours, were transduced with the adenoviral vectors for
wild-type or dominant-negative PKCα or with empty vectors. After an additional 24
hours, transduced cells were seeded on coverslips and analyzed the next day.
Astrocytes were stimulated with 2 μg of either Thy-1(RLD)-Fc-beads, Thy-1(RLE)-
Fc-beads or TRAIL-R2-Fc-beads for 10 minutes, or left unstimulated (NS).
Alternatively, astrocytes were stimulated with neuronal CAD cells as reported
(Hermosilla et al., 2008) or with the Thy-1-Fc mutants coupled to protein-A–Sepharose
beads (20 μl) obtained by incubating the beads with supernatants of transiently
transfected HEK293T cells. Immunofluorescence experiments were performed as
described previously (Avalos et al., 2004). Cells were stained with anti-paxillin or
anti-vinculin antibodies followed by secondary antibodies coupled to Alexa Fluor
488 or Cy3. Filamentous actin was stained with phalloidin conjugated to Rhodamine.
Fluorophores were visualized by confocal microscopy in a Carl Zeiss LSM-Pascal
5 confocal microscope and the number of FAs per cell was quantified and analyzed
for statistical significance as described previously (Avalos et al., 2004). In cases where
only the GFP-positive cell population was analyzed (siRNA and truncated syndecan-
4 experiments), the percentage of GFP-positive cells with augmented FA formation
was estimated. In general, cells were considered as stimulated when at least a 1.5-
fold increase in the number of FAs was detectable compared to the non-stimulated
control cells.
Silencing of syndecan-4
Three pre-designed sense and antisense siRNA oligonucleotides for syndecan-4 were
obtained from Ambion. The target sequences were exon 3 (referred to as oligo 1),
exon 3,4 (oligo 2) and exon 4 (oligo 3). Silencing was evaluated for all possible
siRNA combinations (1+2, 1+3, 2+3 and 1+2+3) by RT-PCR and optimal silencing
conditions were confirmed by western blotting with 3G10 antibody after digestion
with heparitinase. Silencer Negative Control #1 siRNA (Ambion) was used as a control
for specificity.
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